News

CK1d Inhibitors Reduce Alzheimer’s Tau Phosphorylation
CK1d Inhibitors Reduce Alzheimer’s Tau Phosphorylation
November 5, 2015

From the 8th Clinical Trials on Alzheimer’s Disease in Barcelona, PS announces that a recently completed study testing its proprietary inhibitors of CK1d reduced the level of tau phosphorylation in a second in vivo model of Alzheimer’s disease tauopathy.